Salt Loading Blunts Central and Peripheral Postexercise Hypotension.


Journal

Medicine and science in sports and exercise
ISSN: 1530-0315
Titre abrégé: Med Sci Sports Exerc
Pays: United States
ID NLM: 8005433

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 15 10 2019
medline: 15 12 2020
entrez: 15 10 2019
Statut: ppublish

Résumé

High salt intake is a widespread cardiovascular risk factor with systemic effects. These effects include an expansion of plasma volume, which may interfere with postexercise hypotension (PEH). However, the effects of high salt intake on central and peripheral indices of PEH remain unknown. We tested the hypothesis that high salt intake would attenuate central and peripheral PEH. Nineteen healthy adults (7 female/12 male; age, 25 ± 4 yr; body mass index, 23.3 ± 2.2 kg·m; V[Combining Dot Above]O2peak, 41.6 ± 8.7 mL·min·kg; systolic blood pressure (BP), 112 ± 9 mm Hg; diastolic BP, 65 ± 9 mm Hg) participated in this double-blind, randomized, placebo-controlled crossover study. Participants were asked to maintain a 2300 mg·d sodium diet for 10 d on two occasions separated by ≥2 wk. Total salt intake was manipulated via ingestion of capsules containing either table salt (3900 mg·d) or placebo (dextrose) during each diet. On the 10th day, participants completed 50 min of cycling at 60% V[Combining Dot Above]O2peak. A subset of participants (n = 8) completed 60 min of seated rest (sham trial). Beat-to-beat BP was measured in-laboratory for 60 min after exercise via finger photoplethysmography. Brachial and central BPs were measured for 24 h after exercise via ambulatory BP monitor. Ten days of high salt intake increased urinary sodium excretion (134 ± 70 (dextrose) vs 284 ± 74 mmol per 24 h (salt), P < 0.001), expanded plasma volume (7.2% ± 10.8%), and abolished PEH during in-laboratory BP monitoring (main effect of diet, P < 0.001). Ambulatory systolic BPs were higher for 12 h after exercise during the salt and sham trials compared with the dextrose trial (average change, 3.6 ± 2.1 mm Hg (dextrose), 9.9 ± 1.4 mm Hg (salt), 9.8 ± 2.5 mm Hg (sham); P = 0.01). Ambulatory central systolic BP was also higher during the salt trial compared with dextrose trial. High salt intake attenuates peripheral and central PEH, potentially reducing the beneficial cardiovascular effects of acute aerobic exercise.

Identifiants

pubmed: 31609296
doi: 10.1249/MSS.0000000000002187
pmc: PMC7144834
mid: NIHMS1549770
pii: 00005768-202004000-00020
doi:

Substances chimiques

Sodium, Dietary 0
Sodium 9NEZ333N27

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

935-943

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM113125
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128388
Pays : United States

Références

J Appl Physiol (1985). 2017 Apr 1;122(4):925-932
pubmed: 28153943
Am J Physiol Regul Integr Comp Physiol. 2018 Oct 1;315(4):R688-R695
pubmed: 29949407
J Hypertens Suppl. 1985 Dec;3(3):S79-81
pubmed: 2856787
Med Sci Sports Exerc. 2001 Nov;33(11):1855-61
pubmed: 11689735
Med Sci Sports Exerc. 1982;14(5):339-43
pubmed: 7154888
J Am Coll Cardiol. 2015 Mar 17;65(10):1042-50
pubmed: 25766952
Hypertension. 2004 Jul;44(1):35-41
pubmed: 15173128
J Appl Physiol. 1974 Aug;37(2):247-8
pubmed: 4850854
Blood Press Monit. 2007 Apr;12(2):113-7
pubmed: 17353655
J Hypertens. 2017 Feb;35(2):291-299
pubmed: 27861249
Hypertension. 2012 Sep;60(3):653-8
pubmed: 22802220
Am J Physiol Heart Circ Physiol. 2018 Aug 1;315(2):H303-H313
pubmed: 30028200
J Physiol. 2012 Nov 1;590(21):5519-28
pubmed: 22907057
Hypertension. 1993 Nov;22(5):653-64
pubmed: 8225525
Med Sci Sports Exerc. 2004 Mar;36(3):533-53
pubmed: 15076798
Med Sci Sports Exerc. 2001 Jun;33(6 Suppl):S438-45; discussion S452-3
pubmed: 11427768
Eur J Appl Physiol. 2014 Mar;114(3):561-78
pubmed: 24197081
J Am Soc Hypertens. 2017 Oct;11(10):627-634
pubmed: 28830669
J Hum Hypertens. 2017 Feb;31(2):145-150
pubmed: 27511475
Exerc Sport Sci Rev. 2001 Apr;29(2):65-70
pubmed: 11337825
Am J Cardiol. 1997 Jul 1;80(1):49-55
pubmed: 9205019
J Am Coll Cardiol. 2018 Jan 16;71(2):109-118
pubmed: 29146532
Exp Physiol. 2013 Jan;98(1):7-18
pubmed: 22872658
J Appl Physiol (1985). 2011 Feb;110(2):468-71
pubmed: 21088211
Circulation. 1996 Mar 1;93(5):1043-65
pubmed: 8598068
Hypertension. 2019 Mar;73(3):587-593
pubmed: 30661474
J Physiol. 2003 Jul 1;550(Pt 1):279-86
pubmed: 12766237
Am Heart J. 1999 Nov;138(5 Pt 1):916-21
pubmed: 10539823
J Hypertens. 2007 Jun;25(6):1105-87
pubmed: 17563527
J Physiol. 1996 Aug 15;495 ( Pt 1):279-88
pubmed: 8866370
Can Fam Physician. 1999 Apr;45:992, 995, 1004-5
pubmed: 10216799
Circulation. 1991 May;83(5):1557-61
pubmed: 2022015
J Appl Physiol (1985). 2000 Nov;89(5):1830-6
pubmed: 11053333
J Physiol. 2009 Jul 15;587(Pt 14):3605-17
pubmed: 19491249
J Physiol. 2003 Oct 15;552(Pt 2):635-44
pubmed: 14561843
Pulse (Basel). 2017 Jan;4(4):180-192
pubmed: 28229053
Scand J Clin Lab Invest. 2011 Feb;71(1):19-29
pubmed: 21091271
Circulation. 1999 Apr 13;99(14):1831-6
pubmed: 10199879
Clin J Sport Med. 2013 Jan;23(1):58-63
pubmed: 22673537
Am J Physiol Regul Integr Comp Physiol. 2011 Feb;300(2):R486-91
pubmed: 21084673
J Hypertens. 2013 Mar;31(3):530-6
pubmed: 23263240
J Appl Physiol (1985). 2015 Jun 15;118(12):1510-5
pubmed: 26078434
Am J Physiol. 1997 Nov;273(5):H2186-91
pubmed: 9374752
Eur Heart J. 2014 Jul;35(26):1719-25
pubmed: 24459197
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248
pubmed: 29146535
Nutr Metab (Lond). 2007 Jan 04;4:1
pubmed: 17204161
Med Sci Sports Exerc. 2012 Sep;44(9):1644-52
pubmed: 22899388
J Appl Physiol (1985). 1993 May;74(5):2566-73
pubmed: 8335593
Am J Physiol. 1996 Feb;270(2 Pt 2):R420-6
pubmed: 8779874

Auteurs

Matthew C Babcock (MC)

Department of Kinesiology and Applied Physiology, University of Delaware, Newark, DE.

Austin T Robinson (AT)

Department of Kinesiology and Applied Physiology, University of Delaware, Newark, DE.

Joseph C Watso (JC)

Department of Kinesiology and Applied Physiology, University of Delaware, Newark, DE.

Kamila U Migdal (KU)

Department of Kinesiology and Applied Physiology, University of Delaware, Newark, DE.

Christopher R Martens (CR)

Department of Kinesiology and Applied Physiology, University of Delaware, Newark, DE.

David G Edwards (DG)

Department of Kinesiology and Applied Physiology, University of Delaware, Newark, DE.

Linda S Pescatello (LS)

Department of Kinesiology, University of Connecticut, Storrs, CT.

William B Farquhar (WB)

Department of Kinesiology and Applied Physiology, University of Delaware, Newark, DE.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH